Total Clarity Wealth Management, Inc. United Therapeutics Corp Transaction History

Total Clarity Wealth Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$210.76 - $249.51 $843 - $998	-4 Reduced 0.34%	1,160 $266,000
Q4 2023 Jan 23, 2024	SELL	$214.88 - $256.94 $1,074 - $1,284	-5 Reduced 0.43%	1,164 $255,000
Q3 2023 Oct 24, 2023	SELL	$211.82 - $248.24 $7,837 - $9,184	-37 Reduced 3.07%	1,169 $264,000
Q2 2023 Jul 24, 2023	BUY	$205.19 - $232.99 $247,459 - $280,985	1,206 New	1,206 $266,000
Q2 2022 Jul 29, 2022	BUY	$174.81 - $241.14 $8,216 - $11,333	47 New	47 $11,000
Q1 2022 Apr 29, 2022	SELL	$166.16 - $213.96 $7,809 - $10,056	-47 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$179.86 - $214.88 $8,453 - $10,099	47 New	47 $9,000
Q2 2021 Jul 26, 2021	SELL	$170.47 - $211.93 $8,012 - $9,960	-47 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$153.94 - $174.85 $7,235 - $8,217	47 New	47 $8,000
Q1 2020 Apr 24, 2020	SELL	$79.39 - $115.35 $3,731 - $5,421	-47 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$78.31 - $95.34 $3,680 - $4,480	47 New	47 $4,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.